Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lymphoma 5 Lung Neoplasms 5 Multiple Myeloma 4 Lymphoma, Large-Cell, Anaplastic 4 Neuroblastoma 3 Neoplasms 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Neurofibromatosis 2 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Paclitaxel 94 Carboplatin 81 Bevacizumab 61 Gemcitabine 35 liposomal doxorubicin 31 pembrolizumab 29 Topotecan 26 Taxes 23 olaparib 22 Immunoglobulin G 17 Disulfides 17 niraparib 16 Docetaxel 16 Cyclophosphamide 16 Cisplatin 14 rucaparib 10 durvalumab 10 Nivolumab 10 Doxorubicin 9 Albumin-Bound Paclitaxel 8 sargramostim 7 pazopanib 7 fludarabine phosphate 7 fludarabine 7 avelumab 7 Ifosfamide 7 epacadostat 6 Trabectedin 6 Sorafenib 6 Magnetic Resonance Spectroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡